Načítá se...
Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid
BACKGROUND: CD4(+)CD25(+) regulatory T (Treg) cells suppress tumor immunity by inhibiting immune cells. Manipulation of Treg cells represents a new strategy for cancer treatment. Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, inhibits the expression of receptor activator of nuclear fact...
Uloženo v:
| Vydáno v: | BMC Immunol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5124310/ https://ncbi.nlm.nih.gov/pubmed/27887569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-016-0183-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|